CTSO
Cytosorbents Corp
Price:  
0.98 
USD
Volume:  
73,246.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO EV/EBITDA

-1209.6%
Upside

As of 2024-02-25, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -1.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 47.77 mil USD. CTSO's TTM EBITDA according to its financial statements is -26.26 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 20.1x - 22.8x 21.4x
Forward P/E multiples 20.5x - 23.3x 22.2x
Fair Price (10.27) - (11.40) (10.87)
Upside -1147.5% - -1263.5% -1209.6%
0.98 USD
Stock Price
(10.87) USD
Fair Price

CTSO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-23 -2.18
2024-02-22 -2.21
2024-02-21 -2.23
2024-02-20 -2.27
2024-02-16 -2.25
2024-02-15 -2.25
2024-02-14 -2.25
2024-02-13 -2.25
2024-02-12 -2.23
2024-02-09 -2.27
2024-02-08 -2.27
2024-02-07 -2.27
2024-02-06 -2.23
2024-02-05 -2.20
2024-02-02 -2.27
2024-02-01 -2.25
2024-01-31 -2.25
2024-01-30 -2.29
2024-01-29 -2.27
2024-01-26 -2.21
2024-01-25 -1.97
2024-01-24 -1.98
2024-01-23 -2.04
2024-01-22 -2.09
2024-01-19 -2.14
2024-01-18 -2.22
2024-01-17 -2.25
2024-01-16 -2.25
2024-01-12 -2.21
2024-01-11 -2.21
2024-01-10 -2.17
2024-01-09 -2.12
2024-01-08 -2.02
2024-01-05 -2.05
2024-01-04 -2.15
2024-01-03 -2.23
2024-01-02 -2.38
2023-12-29 -2.47
2023-12-28 -2.42
2023-12-27 -3.63
2023-12-26 -3.83
2023-12-22 -3.92
2023-12-21 -4.10
2023-12-20 -4.10
2023-12-19 -3.94
2023-12-18 -4.08
2023-12-15 -3.81
2023-12-14 -3.61
2023-12-13 -3.90
2023-12-12 -3.21